Close Menu

NEW YORK (GenomeWeb) – Roche said today that it has received the CE IVD mark for its Cobas HPV assay on the Cobas 6800/8800 systems for cervical cancer screening.

Cobas HPV is a real-time PCR test that provides specific genotyping information for human papillomavirus 16 and 18, the highest-risk types, while simultaneously reporting the 12 other high-risk HPV types as a pooled result.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

May
22

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.